Large Volume Parenteral Market Trends & Forecast: The global large-volume parenteral market size is estimated to reach USD 15.843 billion by 2030, registering a CAGR of 5.05% from 2024 to 2030, according to a new report by Knowledg...
Large Volume Parenteral Market Trends & Forecast:
The global large-volume parenteral market size is estimated to reach USD 15.843 billion by 2030, registering a CAGR of 5.05% from 2024 to 2030, according to a new report by Knowledge Sourcing Intelligence. The large volume parenteral is a form of aqueous solution, which is usually supplied in volumes of 100 ml and 5,000 ml. The LVP is usually utilized to provide fluid replacement therapy. The global large-volume parenteral market is estimated to attain a greater market share during the forecasted timeline, majorly with the increasing prevalence of chronic diseases across the globe. In the cases of chronic diseases, like cancer, diabetes, and CVD, the LVP products are utilized in administrating medications. Similarly, the growing geriatric population is also estimated to boost the growth of the market during the estimated timeline. With the growing aging population, the diseases related to difficulty in swallowing and digesting oral medication increase. Similarly, the rising elderly population also enhances the need for healthcare needs. The growing demand for biosimilar and biologics are also forecasted to grow the market during the estimated timeline. ? View a sample of the report or purchase the complete study at: Large Volume Parenteral MarketLarge Volume Parenteral Market Report Highlights:
- The 100 ml - 250 ml parenteral category of the volume segment is estimated to attain greater market share by 2030, as the 100 ml - 250 ml parenteral offers multiple applications, which include basic infusion, correction of electrolytes, and fluid balance distribution among others.
- The rising global demand for large-volume parenteral for nutrition applications, is among the key factors propelling the growth of the market during the estimated timeline. In nutritional applications, LVPs are utilized for full nutritional support and offer various forms of essential nutrients.
- The glass bottle LVP solutions, under the packaging container segment are estimated to attain a greater market share during the forecasted timeline. The glass bottle LVP solutions offer application across nutrition, administrating other drugs, and intravenous infusions among others. The glass bottle LVP solutions are commonly utilized in the admirative sector, majorly as they feature a non-reactive nature.
- The Asia Pacific region is estimated to attain a greater market growth rate, majorly due to the increasing prevalence of chronic diseases in the region. Similarly, the growing advancement in the healthcare sector is also estimated to propel the global large-volume parenteral market in the region.
- North America is anticipated to see steady growth, fueled by advancement in the pharmaceutical and healthcare sectors. The North American region witnessed a major growth in healthcare expenditure and pharmaceutical production, enriching the demand for the large volume of parenteral in the region.
Large Volume Parenteral Market Segmentation:
Knowledge Sourcing Intelligence has segmented the global large-volume parenteral market based on volume, application, packaging container, and region: Large Volume Parenteral Market, By Volume- 100 ml - 250 ml
- 250 ml - 500 ml
- Above 500 ml
- Correction of electrolyte & fluid balance disturbances
- Nutrition
- Vehicle for administering other drugs
- Glass Bottle
- Plastic Bags
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
Large Volume Parenteral Market Key Players:
- Fresenius Kabi AG
- Albert David Ltd.
- Otsuka Holdings Co., Ltd.
- Grifols S.A.
- B. Braun Melsungen AG
- BML Parenteral Drugs
- Akums Drugs & Pharmaceuticals Ltd.
- DJ Labs
- Parenteral Drugs (India) Limited
- BKRS Pharma Pvt. Ltd.
- Pfizer
- Baxter
- August Bioservices
- INCOG BioPharma Services
- Simtra BioPharma Solutions
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.